HIMS HERS HEALTH INC CLASS A (HIMS) — insider trading
Health Care · NYSE
HIMS HERS HEALTH INC CLASS A (HIMS) has 191 reported SEC Form 4 insider transactions in our data, including 20 open-market sales among the most recent 100 (latest 2026-10-01).
Recent Form 4 transactions
Showing the 100 most recent of 191 recorded transactions. See all on SEC EDGAR →
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-10-01 | Okupe Oluyemi | Officer (Chief Financial Officer) | Open-market sale | 2,000 | $29.70 | $59.4K | Form 4 |
| 2026-09-30 | Boughton Soleil | Officer (Chief Legal Officer) | Open-market sale | 3,461 | $29.17 | $101.0K | Form 4 |
| 2026-09-22 | Okupe Oluyemi | Officer (Chief Financial Officer) | Option exercise / conversion (derivative) | 14,000 | — | $0 | Form 4 |
| 2026-09-22 | Okupe Oluyemi | Officer (Chief Financial Officer) | Open-market sale | 29,277 | $29.95 | $876.8K | Form 4 |
| 2026-09-22 | Okupe Oluyemi | Officer (Chief Financial Officer) | Option exercise / conversion | 14,000 | $5.01 | $70.1K | Form 4 |
| 2026-09-17 | Okupe Oluyemi | Officer (Chief Financial Officer) | Open-market sale | 12,313 | $28.82 | $354.9K | Form 4 |
| 2026-09-16 | Boughton Soleil | Officer (Chief Legal Officer) | Open-market sale | 6,236 | $27.86 | $173.7K | Form 4 |
| 2026-09-15 | Elshenawy Mohamed | Officer (CTO) | Open-market sale | 7,954 | $28.39 | $225.8K | Form 4 |
| 2026-09-15 | Chi Michael | Officer (Chief Operating Officer) | Open-market sale | 14,027 | $28.39 | $398.2K | Form 4 |
| 2026-09-02 | Boughton Soleil | Officer (Chief Legal Officer) | Open-market sale | 3,458 | $28.33 | $98.0K | Form 4 |
| 2026-08-27 | Dudum Andrew | Director, Officer (Chief Executive Officer), 10% owner | Other acquisition or disposition | 977,566 | — | $0 | Form 4 |
| 2026-08-25 | Dudum Andrew | Director, Officer (Chief Executive Officer), 10% owner | Bona fide gift | 463,289 | — | $0 | Form 4 |
| 2026-08-19 | Boughton Soleil | Officer (Chief Legal Officer) | Open-market sale | 25,111 | $27.55 | $691.8K | Form 4 |
| 2026-08-19 | Okupe Oluyemi | Officer (Chief Financial Officer) | Option exercise / conversion (derivative) | 4,938 | — | $0 | Form 4 |
| 2026-08-19 | Okupe Oluyemi | Officer (Chief Financial Officer) | Open-market sale | 4,938 | $29.99 | $148.1K | Form 4 |
| 2026-08-19 | Okupe Oluyemi | Officer (Chief Financial Officer) | Option exercise / conversion | 4,938 | $5.01 | $24.7K | Form 4 |
| 2026-08-18 | Autor Deborah M. | Director, Officer (Chief Policy Officer) | Open-market sale | 16,773 | $27.85 | $467.1K | Form 4 |
| 2026-08-17 | Okupe Oluyemi | Officer (Chief Financial Officer) | Option exercise / conversion (derivative) | 9,388 | — | $0 | Form 4 |
| 2026-08-17 | Okupe Oluyemi | Officer (Chief Financial Officer) | Open-market sale | 9,388 | $27.89 | $261.8K | Form 4 |
| 2026-08-17 | Okupe Oluyemi | Officer (Chief Financial Officer) | Option exercise / conversion | 9,388 | $5.01 | $47.0K | Form 4 |
| 2026-08-14 | Payne Christopher D | Director | Option exercise / conversion (derivative) | 545 | — | $0 | Form 4 |
| 2026-08-14 | Payne Christopher D | Director | Option exercise / conversion | 545 | — | — | Form 4 |
| 2026-08-14 | Becklund Irene | Officer (PAO) | Option exercise / conversion (derivative) | 3,880 | — | $0 | Form 4 |
| 2026-08-14 | Becklund Irene | Officer (PAO) | Option exercise / conversion (derivative) | 1,394 | — | $0 | Form 4 |
| 2026-08-14 | Becklund Irene | Officer (PAO) | Option exercise / conversion (derivative) | 4,345 | — | $0 | Form 4 |
| 2026-08-14 | Becklund Irene | Officer (PAO) | Option exercise / conversion (derivative) | 4,066 | — | $0 | Form 4 |
| 2026-08-14 | Becklund Irene | Officer (PAO) | Shares withheld for taxes / exercise cost | 6,490 | $28.15 | $182.7K | Form 4 |
| 2026-08-14 | Becklund Irene | Officer (PAO) | Option exercise / conversion | 13,685 | — | — | Form 4 |
| 2026-08-14 | Elshenawy Mohamed | Officer (CTO) | Option exercise / conversion (derivative) | 100,000 | — | $0 | Form 4 |
| 2026-08-14 | Elshenawy Mohamed | Officer (CTO) | Option exercise / conversion (derivative) | 23,514 | — | $0 | Form 4 |
| 2026-08-14 | Elshenawy Mohamed | Officer (CTO) | Option exercise / conversion (derivative) | 64,771 | — | $0 | Form 4 |
| 2026-08-14 | Elshenawy Mohamed | Officer (CTO) | Shares withheld for taxes / exercise cost | 95,798 | $28.15 | $2.70M | Form 4 |
| 2026-08-14 | Elshenawy Mohamed | Officer (CTO) | Option exercise / conversion | 188,285 | — | — | Form 4 |
| 2026-08-14 | WELLS DAVID B | Director | Option exercise / conversion (derivative) | 778 | — | $0 | Form 4 |
| 2026-08-14 | WELLS DAVID B | Director | Option exercise / conversion | 778 | — | — | Form 4 |
| 2026-08-14 | Autor Deborah M. | Director, Officer (Chief Policy Officer) | Option exercise / conversion (derivative) | 32,920 | — | $0 | Form 4 |
| 2026-08-14 | Autor Deborah M. | Director, Officer (Chief Policy Officer) | Shares withheld for taxes / exercise cost | 16,147 | $28.15 | $454.5K | Form 4 |
| 2026-08-14 | Autor Deborah M. | Director, Officer (Chief Policy Officer) | Option exercise / conversion | 32,920 | — | — | Form 4 |
| 2026-08-14 | Okupe Oluyemi | Officer (Chief Financial Officer) | Option exercise / conversion (derivative) | 18,811 | — | $0 | Form 4 |
| 2026-08-14 | Okupe Oluyemi | Officer (Chief Financial Officer) | Option exercise / conversion (derivative) | 11,482 | — | $0 | Form 4 |
| 2026-08-14 | Okupe Oluyemi | Officer (Chief Financial Officer) | Option exercise / conversion (derivative) | 22,988 | — | $0 | Form 4 |
| 2026-08-14 | Okupe Oluyemi | Officer (Chief Financial Officer) | Option exercise / conversion (derivative) | 18,335 | — | $0 | Form 4 |
| 2026-08-14 | Okupe Oluyemi | Officer (Chief Financial Officer) | Shares withheld for taxes / exercise cost | 36,437 | $28.15 | $1.03M | Form 4 |
| 2026-08-14 | Okupe Oluyemi | Officer (Chief Financial Officer) | Option exercise / conversion | 71,616 | — | — | Form 4 |
| 2026-08-14 | Chi Michael | Officer (Chief Operating Officer) | Option exercise / conversion (derivative) | 23,514 | — | $0 | Form 4 |
| 2026-08-14 | Chi Michael | Officer (Chief Operating Officer) | Option exercise / conversion (derivative) | 10,600 | — | $0 | Form 4 |
| 2026-08-14 | Chi Michael | Officer (Chief Operating Officer) | Option exercise / conversion (derivative) | 19,358 | — | $0 | Form 4 |
| 2026-08-14 | Chi Michael | Officer (Chief Operating Officer) | Option exercise / conversion (derivative) | 16,297 | — | $0 | Form 4 |
| 2026-08-14 | Chi Michael | Officer (Chief Operating Officer) | Option exercise / conversion (derivative) | 16,496 | — | $0 | Form 4 |
| 2026-08-14 | Chi Michael | Officer (Chief Operating Officer) | Shares withheld for taxes / exercise cost | 47,702 | $28.15 | $1.34M | Form 4 |
| 2026-08-14 | Chi Michael | Officer (Chief Operating Officer) | Option exercise / conversion | 86,265 | — | — | Form 4 |
| 2026-08-14 | Dudum Andrew | Director, Officer (Chief Executive Officer), 10% owner | Option exercise / conversion (derivative) | 25,865 | — | $0 | Form 4 |
| 2026-08-14 | Dudum Andrew | Director, Officer (Chief Executive Officer), 10% owner | Option exercise / conversion (derivative) | 19,151 | — | $0 | Form 4 |
| 2026-08-14 | Dudum Andrew | Director, Officer (Chief Executive Officer), 10% owner | Option exercise / conversion (derivative) | 74,530 | — | $0 | Form 4 |
| 2026-08-14 | Dudum Andrew | Director, Officer (Chief Executive Officer), 10% owner | Option exercise / conversion (derivative) | 35,447 | — | $0 | Form 4 |
| 2026-08-14 | Dudum Andrew | Director, Officer (Chief Executive Officer), 10% owner | Shares withheld for taxes / exercise cost | 78,859 | $28.15 | $2.22M | Form 4 |
| 2026-08-14 | Dudum Andrew | Director, Officer (Chief Executive Officer), 10% owner | Option exercise / conversion | 154,993 | — | — | Form 4 |
| 2026-08-14 | Carroll Patrick Harrison | Officer (Chief Medical Officer) | Option exercise / conversion (derivative) | 9,406 | — | $0 | Form 4 |
| 2026-08-14 | Carroll Patrick Harrison | Officer (Chief Medical Officer) | Option exercise / conversion (derivative) | 3,533 | — | $0 | Form 4 |
| 2026-08-14 | Carroll Patrick Harrison | Officer (Chief Medical Officer) | Option exercise / conversion (derivative) | 4,839 | — | $0 | Form 4 |
| 2026-08-14 | Carroll Patrick Harrison | Officer (Chief Medical Officer) | Option exercise / conversion (derivative) | 8,149 | — | $0 | Form 4 |
| 2026-08-14 | Carroll Patrick Harrison | Officer (Chief Medical Officer) | Option exercise / conversion (derivative) | 260 | — | $0 | Form 4 |
| 2026-08-14 | Carroll Patrick Harrison | Officer (Chief Medical Officer) | Shares withheld for taxes / exercise cost | 10,201 | $28.15 | $287.2K | Form 4 |
| 2026-08-14 | Carroll Patrick Harrison | Officer (Chief Medical Officer) | Option exercise / conversion | 25,927 | — | — | Form 4 |
| 2026-08-14 | Carroll Patrick Harrison | Officer (Chief Medical Officer) | Option exercise / conversion | 260 | — | — | Form 4 |
| 2026-08-14 | Schultz Kare | Director | Option exercise / conversion (derivative) | 6,623 | — | $0 | Form 4 |
| 2026-08-14 | Schultz Kare | Director | Option exercise / conversion | 6,623 | — | — | Form 4 |
| 2026-08-14 | Boughton Soleil | Officer (Chief Legal Officer) | Option exercise / conversion (derivative) | 11,757 | — | $0 | Form 4 |
| 2026-08-14 | Boughton Soleil | Officer (Chief Legal Officer) | Option exercise / conversion (derivative) | 6,182 | — | $0 | Form 4 |
| 2026-08-14 | Boughton Soleil | Officer (Chief Legal Officer) | Option exercise / conversion (derivative) | 12,099 | — | $0 | Form 4 |
| 2026-08-14 | Boughton Soleil | Officer (Chief Legal Officer) | Option exercise / conversion (derivative) | 12,223 | — | $0 | Form 4 |
| 2026-08-14 | Boughton Soleil | Officer (Chief Legal Officer) | Shares withheld for taxes / exercise cost | 21,500 | $28.15 | $605.2K | Form 4 |
| 2026-08-14 | Boughton Soleil | Officer (Chief Legal Officer) | Option exercise / conversion | 42,261 | — | — | Form 4 |
| 2026-08-12 | Amoo-Gottfried Kofi Owusu | Director | Grant / award / vesting (derivative) | 8,223 | — | $0 | Form 4 |
| 2026-08-12 | Amoo-Gottfried Kofi Owusu | Director | Grant / award / vesting (derivative) | 13,157 | — | $0 | Form 4 |
| 2026-08-12 | WELLS DAVID B | Director | Grant / award / vesting (derivative) | 778 | — | $0 | Form 4 |
| 2026-08-12 | WELLS DAVID B | Director | Grant / award / vesting (derivative) | 8,223 | — | $0 | Form 4 |
| 2026-08-12 | Carroll Patrick Harrison | Officer (Chief Medical Officer) | Grant / award / vesting (derivative) | 260 | — | $0 | Form 4 |
| 2026-08-12 | Autor Deborah M. | Director, Officer (Chief Policy Officer) | Grant / award / vesting (derivative) | 8,223 | — | $0 | Form 4 |
| 2026-08-12 | Cosgrove Delos M. | Director | Grant / award / vesting (derivative) | 8,223 | — | $0 | Form 4 |
| 2026-08-12 | Manuel Anja | Director | Grant / award / vesting (derivative) | 8,223 | — | $0 | Form 4 |
| 2026-08-12 | Perez Garcia Andrea G | Director | Grant / award / vesting (derivative) | 8,223 | — | $0 | Form 4 |
| 2026-08-12 | Payne Christopher D | Director | Grant / award / vesting (derivative) | 545 | — | $0 | Form 4 |
| 2026-08-12 | Payne Christopher D | Director | Grant / award / vesting (derivative) | 8,223 | — | $0 | Form 4 |
| 2026-08-12 | Schultz Kare | Director | Grant / award / vesting (derivative) | 8,223 | — | $0 | Form 4 |
| 2026-08-12 | Elshenawy Mohamed | Officer (CTO) | Grant / award / vesting (derivative) | 1,200,000 | — | $0 | Form 4 |
| 2026-07-17 | Okupe Oluyemi | Officer (Chief Financial Officer) | Option exercise / conversion (derivative) | 7,163 | — | $0 | Form 4 |
| 2026-07-17 | Okupe Oluyemi | Officer (Chief Financial Officer) | Open-market sale | 7,163 | $31.99 | $229.2K | Form 4 |
| 2026-07-17 | Okupe Oluyemi | Officer (Chief Financial Officer) | Option exercise / conversion | 7,163 | $5.01 | $35.9K | Form 4 |
| 2026-07-06 | Okupe Oluyemi | Officer (Chief Financial Officer) | Option exercise / conversion (derivative) | 7,163 | — | $0 | Form 4 |
| 2026-07-06 | Okupe Oluyemi | Officer (Chief Financial Officer) | Open-market sale | 7,163 | $36.49 | $261.4K | Form 4 |
| 2026-07-06 | Okupe Oluyemi | Officer (Chief Financial Officer) | Option exercise / conversion | 7,163 | $5.01 | $35.9K | Form 4 |
| 2026-06-22 | Okupe Oluyemi | Officer (Chief Financial Officer) | Option exercise / conversion (derivative) | 6,376 | — | $0 | Form 4 |
| 2026-06-22 | Okupe Oluyemi | Officer (Chief Financial Officer) | Open-market sale | 18,197 | $34.03 | $619.2K | Form 4 |
| 2026-06-22 | Okupe Oluyemi | Officer (Chief Financial Officer) | Option exercise / conversion | 6,376 | $5.01 | $31.9K | Form 4 |
| 2026-06-18 | Okupe Oluyemi | Officer (Chief Financial Officer) | Open-market sale | 55,383 | $35.09 | $1.94M | Form 4 |
| 2026-06-18 | Carroll Patrick Harrison | Officer (Chief Medical Officer) | Open-market sale | 23,726 | $35.00 | $830.4K | Form 4 |
| 2026-06-17 | Elshenawy Mohamed | Officer (CTO) | Open-market sale | 30,040 | $31.50 | $946.3K | Form 4 |
| 2026-06-17 | Becklund Irene | Officer (PAO) | Open-market sale | 4,490 | $31.50 | $141.4K | Form 4 |
| 2026-06-17 | Chi Michael | Officer (Chief Operating Officer) | Open-market sale | 14,027 | $31.50 | $441.9K | Form 4 |
Ask the chat about HIMS's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: HIMS HERS HEALTH INC CLASS A (HIMS).
Last updated 2026-10-01 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.